Cookies & Privacy

We use essential cookies to make our site work. With your permission, we’ll also use analytics and marketing cookies to improve your experience. You can change your choice anytime.

See our Privacy Policy for details.

Manage preferences
Cookie preferences
Back to Industry News
General

EQL Pharma Issues Profit Warning After Delivery Delays: Dagens industri

Summary generated with AI, editor-reviewed
Heartspace News Desk
Source: Dagens industri
general related image for: EQL Pharma Issues Profit Warning After Delivery Delays: Dagens industri

Photo by Erik Mclean on Unsplash

Key takeaways

  • Kameo, a financing company, promotes itself as a streamlined and adaptable alternative to traditional banks for real estate project funding in a sponsored article
  • General Manager Fredrik Källgren reports that Kameo has facilitated 8 billion SEK in loans for Scandinavian property projects since its 2016 inception
  • Kameo differentiates itself by financing projects starting at 10 million SEK and offering financing plans within weeks, a significantly shorter timeframe compared to the typical 6–12 month approval process at traditional banks
Kameo, a financing company, promotes itself as a streamlined and adaptable alternative to traditional banks for real estate project funding in a sponsored article. General Manager Fredrik Källgren reports that Kameo has facilitated 8 billion SEK in loans for Scandinavian property projects since its 2016 inception. Kameo differentiates itself by financing projects starting at 10 million SEK and offering financing plans within weeks, a significantly shorter timeframe compared to the typical 6–12 month approval process at traditional banks. Furthermore, Kameo provides financing for residential projects without requiring pre-sold units. Funding is derived from Kameo's internal credit fund, institutional partnerships, and its investor platform network. Owned by ABG Sundal Collier and Incore Invest, Kameo reports a low credit loss rate of 0.1 percent on completed loans. The article explicitly discloses its collaborative production with Kameo and its independent status from Dagens industri.

Related Topics

EQL Pharmaprofit warningdelivery delayspharmaceuticalsfinancial performance

Share Your Thoughts

(0 comments)

Be the first to share your thoughts on this article!

Stay Updated

Create alertsRead original